DR Horton Company Top Insiders
DHI Stock | USD 145.88 0.14 0.1% |
Under 90 percent of DR Horton's insiders are activelly selling. The analysis of insiders' sentiment of trading DR Horton stock suggests that a large number of insiders are panicking at this time. DR Horton employs about 13.4 K people. The company is managed by 16 executives with a total tenure of roughly 144 years, averaging almost 9.0 years of service per executive, having 840.63 employees per reported executive.
David Auld CEO President, Chief Executive Officer |
Donald Horton Chairman Executive Chairman of the Board |
DR Horton's Insider Buying Vs Selling
10
Selling | Buying |
Latest Trades
2024-03-20 | David V Auld | Disposed 25000 @ 156.33 | View | ||
2024-03-14 | Barbara K Allen | Disposed 449 @ 149.39 | View | ||
2024-01-30 | Barbara K Allen | Disposed 1748 @ 143.26 | View | ||
2023-12-14 | Bradley S Anderson | Disposed 10000 @ 152 | View | ||
2023-12-11 | Josh Gottheimer | Acquired @ 138.9 | |||
2023-11-28 | Barbara K Allen | Disposed 470 @ 126.21 | View | ||
2023-08-07 | Michael R Buchanan | Disposed 1639 @ 127.03 | View | ||
2023-06-20 | Bill W Wheat | Disposed 32000 @ 117.81 | View | ||
2023-05-17 | Paul J Romanowski | Disposed 40000 @ 112.16 | View | ||
2023-05-03 | Michael J Murray | Disposed 54000 @ 110.21 | View |
Monitoring DR Horton's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment refers to the collective sentiment or feeling of DR Horton's insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of DR Horton. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe DR Horton's stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
DHI |
DR Horton's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with DR Horton's future performance. Based on our forecasts, it is anticipated that DHI will maintain a workforce of under 13450 employees by May 2024.DR Horton's latest congressional trading
Congressional trading in companies like DR Horton, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in DR Horton by those in governmental positions are based on the same information available to the general public.
2024-03-14 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
2022-10-05 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
2020-08-05 | Senator Ron Wyden | Acquired Under $15K | Verify |
DR Horton Management Team Effectiveness
The company has Return on Asset of 0.1216 % which means that on every $100 spent on assets, it made $0.1216 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2166 %, implying that it generated $0.2166 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.37, while Return On Tangible Assets are projected to decrease to 0.05. As of now, DR Horton's Other Current Assets are increasing as compared to previous years. The DR Horton's current Total Current Assets is estimated to increase to about 34.8 B, while Intangible Assets are projected to decrease to under 9.5 M.The DR Horton's current Net Income Applicable To Common Shares is estimated to increase to about 5.7 B, while Common Stock Shares Outstanding is projected to decrease to under 320.7 M.
DR Horton Workforce Comparison
DR Horton is one of the top stocks in number of employees category among related companies. The total workforce of Consumer Discretionary industry is currently estimated at about 60,641. DR Horton totals roughly 13,450 in number of employees claiming about 22% of stocks in Consumer Discretionary industry.
DR Horton Profit Margins
The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.16 %, which entails that for every 100 dollars of revenue, it generated $0.16 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.15 | 0.1942 |
|
| |||||
Net Profit Margin | 0.0423 | 0.0467 |
|
| |||||
Operating Profit Margin | 0.0633 | 0.087 |
|
| |||||
Pretax Profit Margin | 0.0605 | 0.0725 |
|
| |||||
Return On Assets | 0.0506 | 0.0972 |
|
| |||||
Return On Equity | 0.37 | 0.3515 |
|
|
DR Horton Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DR Horton insiders, such as employees or executives, is commonly permitted as long as it does not rely on DR Horton's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, DR Horton insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.7193 | 41 | 57 | 89,795 | 145,592 |
2023-12-01 | 0.6 | 21 | 35 | 853,467 | 1,436,021 |
2023-09-01 | 1.0 | 1 | 1 | 1,129,924 | 1,639 |
2023-06-01 | 1.3333 | 16 | 12 | 292,193 | 326,809 |
2023-03-01 | 0.6081 | 45 | 74 | 2,416,266 | 3,098,354 |
2022-12-01 | 0.5 | 17 | 34 | 734,238 | 1,011,783 |
2022-06-01 | 1.5 | 3 | 2 | 91,762 | 19,896 |
2022-03-01 | 0.8281 | 53 | 64 | 288,953 | 198,779 |
2021-12-01 | 0.434 | 23 | 53 | 1,105,716 | 1,539,283 |
2021-09-01 | 0.2 | 1 | 5 | 60,000 | 4,535,582 |
2021-06-01 | 0.6364 | 7 | 11 | 4,697,766 | 528,192 |
2021-03-01 | 0.7377 | 45 | 61 | 821,427 | 1,156,302 |
2020-12-01 | 0.4048 | 17 | 42 | 653,367 | 25,136,378 |
2020-09-01 | 0.3333 | 3 | 9 | 66,000 | 211,034 |
2020-06-01 | 0.5714 | 4 | 7 | 4,000 | 8,833 |
2020-03-01 | 0.7857 | 44 | 56 | 332,813 | 332,874 |
2019-12-01 | 0.5294 | 18 | 34 | 763,227 | 1,292,051 |
2019-09-01 | 0.4 | 2 | 5 | 12,500 | 32,000 |
2019-03-01 | 0.6852 | 37 | 54 | 298,150 | 318,704 |
2018-12-01 | 0.8696 | 20 | 23 | 1,027,382 | 1,128,481 |
2018-09-01 | 0.5 | 1 | 2 | 3,000 | 6,000 |
2018-03-01 | 0.7451 | 38 | 51 | 647,627 | 750,556 |
2017-12-01 | 0.5417 | 13 | 24 | 638,542 | 913,278 |
2017-09-01 | 0.4444 | 4 | 9 | 24,666 | 50,272 |
2017-03-01 | 0.8158 | 31 | 38 | 412,592 | 2,310,854 |
2016-12-01 | 1.0 | 9 | 9 | 425,648 | 504,630 |
2016-09-01 | 0.6364 | 7 | 11 | 27,333 | 59,666 |
2016-06-01 | 0.5714 | 4 | 7 | 223,000 | 414,979 |
2016-03-01 | 1.1667 | 21 | 18 | 351,312 | 95,415 |
2015-12-01 | 0.6364 | 7 | 11 | 353,129 | 468,961 |
2015-09-01 | 0.4444 | 4 | 9 | 77,000 | 3,012,500 |
2015-03-01 | 2.25 | 18 | 8 | 408,721 | 88,221 |
2014-12-01 | 0.5625 | 9 | 16 | 382,359 | 833,508 |
2014-06-01 | 0.7143 | 5 | 7 | 279,100 | 519,447 |
2014-03-01 | 1.0 | 16 | 16 | 482,332 | 306,261 |
2013-12-01 | 0.3333 | 4 | 12 | 498,280 | 1,117,471 |
2013-06-01 | 0.75 | 6 | 8 | 98,499 | 189,498 |
2013-03-01 | 3.0 | 15 | 5 | 441,333 | 42,750 |
2012-12-01 | 0.5 | 2 | 4 | 325,000 | 446,875 |
2012-09-01 | 0.6471 | 11 | 17 | 484,667 | 959,782 |
2012-06-01 | 0.375 | 3 | 8 | 216,000 | 482,982 |
2012-03-01 | 0.5 | 10 | 20 | 364,000 | 869,254 |
2011-12-01 | 2.0 | 2 | 1 | 275,625 | 176,475 |
2010-12-01 | 1.0 | 2 | 2 | 437,500 | 330,182 |
2010-09-01 | 1.0 | 4 | 4 | 209,990 | 14,680 |
2010-03-01 | 0.5 | 2 | 4 | 66,600 | 121,070 |
2009-12-01 | 0.5 | 2 | 4 | 333,000 | 567,672 |
2008-06-01 | 0.5 | 6 | 12 | 45,559 | 61,099 |
2008-03-01 | 0.4865 | 18 | 37 | 1,285,324 | 596,574 |
2007-09-01 | 1.0 | 1 | 1 | 1,816 | 1,816 |
2007-06-01 | 0.625 | 5 | 8 | 286,828 | 300,948 |
2007-03-01 | 0.6667 | 2 | 3 | 24,735 | 35,858 |
2006-09-01 | 1.3333 | 4 | 3 | 22,480 | 22,380 |
2006-06-01 | 2.8 | 14 | 5 | 602,933 | 128,725 |
2006-03-01 | 0.5 | 3 | 6 | 15,503 | 31,006 |
2005-12-01 | 0.75 | 3 | 4 | 14,117 | 14,542 |
2005-09-01 | 1.0 | 3 | 3 | 21,559 | 21,559 |
2005-06-01 | 0.3235 | 11 | 34 | 216,794 | 456,790 |
2005-03-01 | 1.0 | 1 | 1 | 55,566 | 55,566 |
2004-12-01 | 0.6 | 3 | 5 | 13,016 | 17,037 |
2004-09-01 | 2.0 | 2 | 1 | 61,318 | 60,568 |
2004-06-01 | 4.5 | 9 | 2 | 309,297 | 5,835 |
2004-03-01 | 4.0 | 4 | 1 | 32,336 | 4,313 |
2003-12-01 | 0.1961 | 10 | 51 | 153,410 | 173,569 |
2003-09-01 | 0.0597 | 4 | 67 | 60,000 | 834,450 |
DR Horton Notable Stakeholders
A DR Horton stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DR Horton often face trade-offs trying to please all of them. DR Horton's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DR Horton's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David Auld | President, Chief Executive Officer | Profile | |
Donald Horton | Executive Chairman of the Board | Profile | |
Michael Murray | Co-Chief Operating Officer, Executive Vice President | Profile | |
Bill Wheat | Chief Financial Officer, Executive Vice President | Profile | |
Paul Romanowski | Co-Chief Operating Officer, Executive Vice President | Profile | |
Matt Farris | President Region | Profile | |
Michael Buchanan | Independent Director | Profile | |
Michael Hewatt | Independent Director | Profile | |
Barbara Allen | Independent Director | Profile | |
Bradley Anderson | Independent Director | Profile | |
Thomas Montano | Corporate VP | Profile | |
Jessica Hansen | VP of Communications | Profile | |
Maribess Miller | Independent Director | Profile | |
Aron Odom | Principal Accounting Officer | Profile | |
Benjamin Carson | Independent Director | Profile | |
Collin Dawson | Vice Treasurer | Profile |
About DR Horton Management Performance
The success or failure of an entity such as DR Horton often depends on how effective the management is. DR Horton management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DHI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DHI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.1 | 0.05 | |
Return On Capital Employed | 0.52 | 0.55 | |
Return On Assets | 0.1 | 0.05 | |
Return On Equity | 0.35 | 0.37 |
The data published in DR Horton's official financial statements usually reflect DR Horton's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DR Horton. For example, before you start analyzing numbers published by DHI accountants, it's critical to develop an understanding of what DR Horton's liquidity, profitability, and earnings quality are in the context of the Household Durables space in which it operates.
Please note, the presentation of DR Horton's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DR Horton's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DR Horton's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DR Horton. Please utilize our Beneish M Score to check the likelihood of DR Horton's management manipulating its earnings.
DR Horton Workforce Analysis
Traditionally, organizations such as DR Horton use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DR Horton within its industry.DR Horton Manpower Efficiency
Return on DR Horton Manpower
Revenue Per Employee | 2.6M | |
Revenue Per Executive | 2.2B | |
Net Income Per Employee | 356.5K | |
Net Income Per Executive | 299.7M | |
Working Capital Per Employee | 1.8M | |
Working Capital Per Executive | 1.5B |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.Note that the DR Horton information on this page should be used as a complementary analysis to other DR Horton's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for DHI Stock analysis
When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is DR Horton's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Dividend Share 1.05 | Earnings Share 13.87 | Revenue Per Share 106.305 | Quarterly Revenue Growth 0.065 |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.